Combined study of genetic and epigenetic biomarker risperidone treatment efficacy in Chinese Han schizophrenia patients

Nowadays, risperidone is an atypical antipsychotic drug that has been increasingly used for treatment and maintenance therapy in schizophrenia. However, partially affected by genetic or environmental factors, there is significant difference in treatment outcomes among patients. In this study, we aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Y, Li, M, Song, C, Xu, Q, Huo, R, Shen, L, Xing, Q, Cui, D, Li, W, Zhao, J, He, L, Qin, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538123/
https://www.ncbi.nlm.nih.gov/pubmed/28696411
http://dx.doi.org/10.1038/tp.2017.143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538123/
https://www.ncbi.nlm.nih.gov/pubmed/28696411
http://dx.doi.org/10.1038/tp.2017.143

Ejemplares similares